1. Home
  2. ZLAB vs TENB Comparison

ZLAB vs TENB Comparison

Compare ZLAB & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • TENB
  • Stock Information
  • Founded
  • ZLAB 2013
  • TENB 2002
  • Country
  • ZLAB China
  • TENB United States
  • Employees
  • ZLAB N/A
  • TENB N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • TENB Computer Software: Prepackaged Software
  • Sector
  • ZLAB Health Care
  • TENB Technology
  • Exchange
  • ZLAB Nasdaq
  • TENB Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • TENB 4.1B
  • IPO Year
  • ZLAB 2017
  • TENB 2018
  • Fundamental
  • Price
  • ZLAB $30.14
  • TENB $32.22
  • Analyst Decision
  • ZLAB Buy
  • TENB Buy
  • Analyst Count
  • ZLAB 4
  • TENB 19
  • Target Price
  • ZLAB $47.37
  • TENB $40.33
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • TENB 1.5M
  • Earning Date
  • ZLAB 05-08-2025
  • TENB 04-29-2025
  • Dividend Yield
  • ZLAB N/A
  • TENB N/A
  • EPS Growth
  • ZLAB N/A
  • TENB N/A
  • EPS
  • ZLAB N/A
  • TENB N/A
  • Revenue
  • ZLAB $418,326,000.00
  • TENB $923,197,000.00
  • Revenue This Year
  • ZLAB $44.07
  • TENB $10.61
  • Revenue Next Year
  • ZLAB $49.13
  • TENB $7.88
  • P/E Ratio
  • ZLAB N/A
  • TENB N/A
  • Revenue Growth
  • ZLAB 43.72
  • TENB 11.79
  • 52 Week Low
  • ZLAB $16.01
  • TENB $28.75
  • 52 Week High
  • ZLAB $39.77
  • TENB $49.18
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.27
  • TENB 47.65
  • Support Level
  • ZLAB $30.11
  • TENB $31.63
  • Resistance Level
  • ZLAB $31.34
  • TENB $32.76
  • Average True Range (ATR)
  • ZLAB 1.09
  • TENB 0.64
  • MACD
  • ZLAB 0.07
  • TENB 0.05
  • Stochastic Oscillator
  • ZLAB 43.07
  • TENB 30.34

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: